Aclaris Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $53.9M | $251.2M | $27.3M |
| FY2022 | $57.0M | $254.6M | $45.3M |
| FY2023 | $40.2M | $197.4M | $39.9M |
| FY2024 | $64.8M | $220.3M | $24.6M |
| FY2025 | $57.4M | $160.5M | $20.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $53.9M | $251.2M | $27.3M |
| FY2022 | $57.0M | $254.6M | $45.3M |
| FY2023 | $40.2M | $197.4M | $39.9M |
| FY2024 | $64.8M | $220.3M | $24.6M |
| FY2025 | $57.4M | $160.5M | $20.0M |